These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31828526)

  • 1. Acute glycemic variability on admission predicts the prognosis in hospitalized patients with coronary artery disease: a meta-analysis.
    Pu Z; Lai L; Yang X; Wang Y; Dong P; Wang D; Xie Y; Han Z
    Endocrine; 2020 Mar; 67(3):526-534. PubMed ID: 31828526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediabetes predicts adverse cardiovascular outcomes after percutaneous coronary intervention: a meta-analysis.
    Zhao Y; Guo M; Shi G
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31793983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycemic variability determined with a continuous glucose monitoring system can predict prognosis after acute coronary syndrome.
    Takahashi H; Iwahashi N; Kirigaya J; Kataoka S; Minamimoto Y; Gohbara M; Abe T; Okada K; Matsuzawa Y; Konishi M; Maejima N; Hibi K; Kosuge M; Ebina T; Tamura K; Kimura K
    Cardiovasc Diabetol; 2018 Aug; 17(1):116. PubMed ID: 30121076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher Plasma Pentraxin-3 Level Predicts Adverse Clinical Outcomes in Patients With Coronary Artery Disease: A Meta-Analysis of Cohort Studies.
    Ding K; Shi Z; Qian C; Yang X
    Front Cardiovasc Med; 2021; 8():726289. PubMed ID: 35083296
    [No Abstract]   [Full Text] [Related]  

  • 5. Frailty Predicts Poor Prognosis of Patients After Percutaneous Coronary Intervention: A Meta-Analysis of Cohort Studies.
    Wang P; Zhang S; Zhang K; Tian J
    Front Med (Lausanne); 2021; 8():696153. PubMed ID: 34490292
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of the Mean Amplitude of Glycemic Excursions and Vascular Endothelial Dysfunction on Cardiovascular Events in Nondiabetic Patients With Coronary Artery Disease.
    Akasaka T; Sueta D; Tabata N; Takashio S; Yamamoto E; Izumiya Y; Tsujita K; Kojima S; Kaikita K; Matsui K; Hokimoto S
    J Am Heart Assoc; 2017 Apr; 6(5):. PubMed ID: 28446494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of asymmetric dimethylarginine in patients with coronary artery disease: A meta-analysis.
    Ye J; Dai Y; Mao H; Zheng W; Zhang J
    Nitric Oxide; 2021 May; 109-110():50-56. PubMed ID: 33684543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of blood CXCL12 level in prognosis of coronary artery disease: A meta-analysis.
    Zhang S; Ding Y; Feng F; Gao Y
    Front Cardiovasc Med; 2022; 9():938540. PubMed ID: 35966557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copeptin and the prognosis of patients with coronary artery disease: a meta-analysis.
    Shi Z; Qian C
    Ir J Med Sci; 2023 Oct; 192(5):2129-2141. PubMed ID: 36719516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between soluble suppression of tumorigenicity-2 and long-term prognosis in patients with coronary artery disease: A meta-analysis.
    Liu N; Hang T; Gao X; Yang W; Kong W; Lou Q; Yang J
    PLoS One; 2020; 15(9):e0238775. PubMed ID: 32886697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triglyceride-Glukose Index Predicts Adverse Events in Patients with Acute Coronary Syndrome: A Meta-Analysis of Cohort Studies.
    Li J; Ren L; Chang C; Luo L
    Horm Metab Res; 2021 Sep; 53(9):594-601. PubMed ID: 34298566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression predicts the risk of adverse events after percutaneous coronary intervention: A meta-analysis.
    Song X; Song J; Shao M; Gao X; Ji F; Tian H; Xu Y; Zhuo C
    J Affect Disord; 2020 Apr; 266():158-164. PubMed ID: 32056871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of small dense low-density lipoprotein with cardiovascular outcome in patients with coronary artery disease and diabetes: a prospective, observational cohort study.
    Jin JL; Zhang HW; Cao YX; Liu HH; Hua Q; Li YF; Zhang Y; Wu NQ; Zhu CG; Xu RX; Gao Y; Li XL; Cui CJ; Liu G; Sun J; Dong Q; Guo YL; Li JJ
    Cardiovasc Diabetol; 2020 Apr; 19(1):45. PubMed ID: 32245386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Admission glycemic variability correlates with in-hospital outcomes in diabetic patients with non-ST segment elevation acute coronary syndrome undergoing percutaneous coronary intervention.
    Su G; Zhang T; Yang H; Dai W; Tian L; Tao H; Wang T; Mi S
    Anatol J Cardiol; 2018 Jun; 19(6):368-373. PubMed ID: 29848920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Handgrip Strength and Mortality of Patients With Coronary Artery Disease: A Meta-Analysis.
    Xiao M; Lu Y; Li H; Zhao Z
    Clin Cardiol; 2024 Jul; 47(7):e24322. PubMed ID: 39051437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of daily glucose fluctuation on coronary plaque vulnerability in patients pre-treated with lipid-lowering therapy: a prospective observational study.
    Kuroda M; Shinke T; Sakaguchi K; Otake H; Takaya T; Hirota Y; Sugiyama D; Nakagawa M; Hariki H; Inoue T; Osue T; Taniguchi Y; Iwasaki M; Nishio R; Kinutani H; Konishi A; Hiranuma N; Takahashi H; Terashita D; Hirata KI
    JACC Cardiovasc Interv; 2015 May; 8(6):800-811. PubMed ID: 25999102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor-23 as a biomarker of adverse outcomes in patients with coronary artery disease: a meta-analysis.
    Zheng S; Wang C; Yan H; Xu M; Du Y
    Biomarkers; 2022 Jun; 27(4):299-305. PubMed ID: 35254176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycaemic variability and risk of adverse cardiovascular events in acute coronary syndrome.
    Zhang L; Li F; Liu HH; Zhang ZY; Yang F; Qian LL; Wang RX
    Diab Vasc Dis Res; 2022; 19(6):14791641221137736. PubMed ID: 36341514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of adiponectin level in patients with coronary artery disease: a systematic review and meta-analysis.
    Yang L; Li B; Zhao Y; Zhang Z
    Lipids Health Dis; 2019 Dec; 18(1):227. PubMed ID: 31870374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between daily glucose fluctuation and coronary plaque properties in patients receiving adequate lipid-lowering therapy assessed by continuous glucose monitoring and optical coherence tomography.
    Kuroda M; Shinke T; Sakaguchi K; Otake H; Takaya T; Hirota Y; Osue T; Kinutani H; Konishi A; Takahashi H; Terashita D; Uzu K; Hirata K
    Cardiovasc Diabetol; 2015 Jun; 14():78. PubMed ID: 26062762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.